Aalto University, Espoo, Finland.
Terveystalo Plc, Helsinki, Finland.
BMC Public Health. 2024 Nov 9;24(1):3100. doi: 10.1186/s12889-024-20594-7.
Most current studies on COVID-19 have focused on the first weeks or months of the pandemic or have addressed specific diseases. The long-term effects of the COVID-19 pandemic on healthcare services are insufficiently understood. We analysed the long-term effects of the COVID-19 pandemic on outpatient healthcare utilisation in the full spectrum of diseases in Uusimaa, the capital region of Finland.
Our data included 632 466 individual patients between the ages of 18 and 65 and 6 521 394 visits to healthcare personnel from electronic health records. We fitted an autoregressive integrated moving average (ARIMA) model to pre-2020 data to predict the expected quantity of diagnoses for the period between 1 January 2020 and 16 June 2022. Expected and observed quantities of diagnoses were compared.
The overall quantity of diagnoses declined by one-fourth immediately following the onset of the pandemic and remained around 15% below predicted values for most of the pandemic. After the pandemic-related restrictions were lifted, the total diagnostic activity started to recover to pre-pandemic projection levels. However, this recovery has been mainly driven by upper respiratory system-related activity. The number of diagnoses for many diagnosis groups has remained below the predicted levels, even after the concurrent removal of mobility restrictions and increased coverage of vaccinations in this population.
The pandemic resulted in an overall reduction in outpatient healthcare utilisation which persisted for 30 months. While the overall diagnostic activity has eventually recovered to predicted levels, many classes of diagnoses display reduced levels in the study population over the follow-up period. Some diseases that may have long-lasting effects when left untreated seem to remain underdiagnosed, potentially increasing pressure on the healthcare system in the future.
大多数关于 COVID-19 的当前研究都集中在大流行的最初几周或几个月或针对特定疾病。 COVID-19 大流行对医疗保健服务的长期影响尚未得到充分了解。我们分析了 COVID-19 大流行对芬兰首都地区乌西玛全疾病谱的门诊医疗利用的长期影响。
我们的数据包括 632466 名 18 至 65 岁的个体患者和 6521394 次从电子健康记录中获得的医疗保健人员的就诊。我们使用自回归综合移动平均 (ARIMA) 模型对 2020 年前的数据进行拟合,以预测 2020 年 1 月 1 日至 2022 年 6 月 16 日期间的预期诊断量。比较了预期和观察到的诊断数量。
大流行开始后,整体诊断量立即下降了四分之一,并且在大流行的大部分时间里仍保持在预测值的 15%以下。大流行相关限制取消后,总诊断活动开始恢复到大流行前的预测水平。然而,这种复苏主要是由上呼吸道系统相关活动推动的。即使在该人群中取消了出行限制并增加了疫苗接种覆盖率,许多诊断组的诊断数量仍低于预测水平。
大流行导致门诊医疗利用率总体下降,持续了 30 个月。虽然整体诊断活动最终恢复到预测水平,但在随访期间,研究人群中许多诊断类别的诊断水平仍然较低。一些如果得不到治疗可能会产生长期影响的疾病似乎仍然被漏诊,这可能会给未来的医疗系统带来压力。